The University of Chicago Header Logo

Connection

Mark Kozloff to Antimetabolites, Antineoplastic

Back to Details
This is a "connection" page, showing publications Mark Kozloff has written about Antimetabolites, Antineoplastic.
Mark Kozloff
Connection Strength
0.026
Antimetabolites, Antineoplastic
  1. Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors. Invest New Drugs. 2014 Aug; 32(4):700-9.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.